Translation of the Czech and its cancer screening program and its results.

In recent years, global medical institutions and public health systems have continued to advance service capacity building to provide stronger guarantees for public health. The screening program is a key component of secondary prevention, with the goal of detecting diseases at an early stage. In the Czech Republic, five cancer screening programs are currently covered by the full public health insurance coverage.

These include early screening for breast cancer, colorectal cancer and cervical cancer, as well as early screening and pilot screening for lung and prostate tumors. The purpose of this communication is to present national programmes and analyze the results of evaluations of their key performance indicators. Based on data from the National Health Information System, regular monitoring and evaluation of screening programs are fully evaluated.

The basic indicators are typical of epidemiological characteristics such as incidence and mortality, but also include quality indicators of screening programs, such as the coverage of target populations or the proportion of abnormal screening test results. Analysis output shows that incidence and mortality rates for colorectal and cervical cancer are continuously declining. The target population coverage for breast cancer and cervical cancer screening is 60%, and that for colorectal cancer screening is more than 30%.

As part of the early detection of lung cancer, nearly 200,000 (about 2. 5 million, 0. 9%) or ex-smokers were screened during the past 3.

5 years, and in more than 3% of cases, the radioactive positive results found in the first screening were detected on the first day of the first screening, requiring further investigation. In the past 1. 5 years, about 9% of men have participated in early detection of prostate cancer, of which about 2.

5 million (about 2. 5 million, 0. 9%) or ex-smokers have been screened for radioactive positive results on the first day of the first screening, requiring further investigation.

In the past 1. 5 years, about 9% of men have participated in early detection of prostate cancer, of which about 2. 5 million (about 2.

5 million, 0. 9%) or ex-smokers have been screened for radioactive positive results on the first day of the first screening, requiring further investigation. In the past 1.

5 years, about 9% of men have participated in early detection of prostate cancer, of which about 2. 5 million (about 2. 5 million, 0.

9%) or ex-smokers have been screened for radioactive positive results on the first day of the first screening, requiring further investigation. In the past 1. 5 years, about 9% of men participated in early detection of prostate cancer, of which about 2.

5 million (about 2. 5 million, 0. 9%) or ex-smokers were screened for radiation-positive results on the first day of the first screening in the past 3.

5 years, and further investigation is needed.